Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Spyre Therapeutics (SYRE) Q4 2020 Earnings
SYRE
18
Mar
Expected
Q1 2020
Q2 2020
Q3 2020
Q4 2020
-14.25
-9.61
-4.98
-0.34
Details
Expected EPS
-0.3429
Actual EPS
-8.75
Surprise EPS
-8.41
Surprise Percent
+2,451.76%
Description
Spyre Therapeutics (SYRE) has reported earnings of -8.75 per share for Q4 2020.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login